Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials-Reference-Cited by-同舟云学术

Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Published:2019-01 Issue:1 Volume:80 Page:128-138.e2
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Glaser Dee Anna,Hebert Adelaide A.,Nast Alexander,Werschler William P.,Green Lawrence,Mamelok Richard,Drew Janice,Quiring John,Pariser David M.

Publisher

Elsevier BV

Subject

Dermatology

Reference22 articles.

1. Hyperhidrosis: an update on prevalence and severity in the United States;Doolittle;Arch Dermatol Res,2016

2. Current and emerging medical therapies for primary hyperhidrosis;Grabell;Dermatol Ther (Heidelb),2017

3. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results;Amir;Isr J Psychiatry Relat Sci,2000

4. The Illness Intrusiveness Rating Scale: a measure of severity in individuals with hyperhidrosis;Cina;Qual Life Res,1999

5. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey;Strutton;J Am Acad Dermatol,2004

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Topical Anticholinergics in the Management of Focal Hyperhidrosis in Adults and Children. A Narrative Review;Actas Dermo-Sifiliográficas;2024-04

2. Dermatologic Conditions in Persons with Lower Limb Amputations: a Review;Current Physical Medicine and Rehabilitation Reports;2024-01-05

3. Tratamiento farmacológico de la hiperhidrosis primaria;Piel;2023-10

4. Anticolinérgicos tópicos en el manejo de la hiperhidrosis focal en adultos y niños. Una revisión narrativa;Actas Dermo-Sifiliográficas;2023-09

5. Urinary retention and mydriasis secondary to topical glycopyrronium for axillary hyperhidrosis;American Journal of Health-System Pharmacy;2023-06-22